Results 121 to 130 of about 201,288 (355)
Increasing Herd Immunity with Influenza Revaccination [PDF]
Seasonal influenza is a significant public health concern in the United States and globally. While influenza vaccines are the single most effective intervention to reduce influenza morbidity and mortality, there is considerable debate surrounding the merits and consequences of repeated seasonal vaccination.
arxiv
Influenza Virus Vaccine Efficacy Based On Conserved Sequence Alignment [PDF]
The rapid outbreak of bird flu challenges the outcome of effective vaccine for the upcoming years. The recent research established different norms to eliminate flu pandemics. This can be made possible with skilled experimental analyses and by tracking the recent virulent strain and can be broadly applicable with effective testing of vaccine efficacy ...
arxiv +1 more source
LNPsD18, a cationic liposome that enhances antigen‐presenting cell uptake in the spleen and tumor without targeting ligands is developed. Co‐delivering neoantigens and a TLR9 agonist significantly improve DC activation, tumor immunity, and survival in liver and colorectal cancer models, demonstrating the importance of dual‐site APC targeting for cancer
Yu Xu+12 more
wiley +1 more source
Predicting influenza H3N2 vaccine efficacy from evolution of the dominant epitope [PDF]
We predict vaccine efficacy with a measure of antigenic distance between influenza A(H3N2) and candidate vaccine viruses based on amino acid substitutions in the dominant epitopes. In 2016-2017, our model predicts 19% efficacy compared to 20% observed.
arxiv
Reduction in respiratory mortality not associated with influenza in Russia: effect of the introduction of pneumococcal vaccination (PCV13), or improvement in care? [PDF]
Background. Pneumococcal vaccination (PCV13) for children (as well as older adults) in Russia was introduced in 2014, with no prior PCV7 use. While pneumonia hospitalization rates, both in children and adults did not decrease in the following years, respiratory mortality rates did decline with time.
arxiv
PRIZE, a P53‐repair nanosystem based on a virus‐mimicking nanostructure, delivers p53 mRNA into tumor cells, restoring P53 levels and enhancing immunogenicity. Its biomineralized structure stabilizes the mRNA, prolongs P53's half‐life, and precisely targets tumors.
Yan Liang+10 more
wiley +1 more source
Safety and immunogenicity of mRNA COVID‐19 vaccine in inpatients with muscular dystrophy
Abstract Introduction/Aims Due to muscular weakness and cardiopulmonary dysfunction, patients with muscular dystrophy (MD) have an increased risk of serious complications from coronavirus disease‐2019 (COVID‐19). Although vaccination is recommended, COVID‐19 vaccination safety and immunogenicity in these patients are unknown.
Tomoko Saito+9 more
wiley +1 more source
Religious Festivals and Influenza [PDF]
Objectives Influenza outbreaks have been widely studied. However, the patterns between influenza and religious festivals remained unexplored. This study examined the patterns of influenza and Hanukkah in Israel, and that of influenza and Hajj in Bahrain, Egypt, Iraq, Jordan, Oman and Qatar.
arxiv
Individual vaccination as Nash equilibrium in a SIR model with application to the 2009-10 Influenza A(H1N1) epidemic in France [PDF]
The vaccination against ongoing epidemics is seldom compulsory but remains one of the most classical means to fight epidemic propagation. However recent debates concerning the innocuity of vaccines and their risk with respect to the risk of the epidemic itself lead to severe vaccination campaign failures and new mass behaviors appeared driven by ...
arxiv +1 more source
Pandemic Influenza Vaccines [PDF]
Since their compositions remain uncertain, universal pandemic vaccines are yet to be created. They would aim to protect globally against pandemic influenza viruses that have not yet evolved. Thus they differ from seasonal vaccines to influenza virus, which are updated annually in spring to incorporate the latest circulating viruses, and are then ...
Lauren J. DiMenna, Hildegund C. J. Ertl
openaire +3 more sources